We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEI
11926
PUT
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$86K ﹤0.01%
9,127
-4,720
-34% -$62.9K
ANNX icon
11927
Annexon
ANNX
$942M
$85K ﹤0.01%
31,160
-14,310
-31% -$88.1K
AWRE icon
11928
CALL
Aware
AWRE
$27.5M
$85K ﹤0.01%
28,200
-1,400
-5% -$4.34K
CANG
11929
Cango Inc
CANG
$91.5M
$85K ﹤0.01%
3,264
+1,969
+152% +$61.1K
GLBS icon
11930
Globus Maritime Ltd
GLBS
$76.4M
$85K ﹤0.01%
37,138
-46,870
-56% -$97.7K
BRDS
11931
DELISTED
Bird Global, Inc.
BRDS
$85K ﹤0.01%
+1,392
New +$124K
BCTXW
11932
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$84K ﹤0.01%
+16,092
New +$64.1K
ADAM
11933
CALL
Adamas Trust
ADAM
$881M
$84K ﹤0.01%
5,775
-89,425
-94% -$1.31M
IVF
11934
INVO Fertility Inc
IVF
$2.51M
$84K ﹤0.01%
+1
New +$86.7K
CFRX
11935
PUT
DELISTED
ContraFect Corporation
CFRX
$84K ﹤0.01%
288
-592
-67% -$144K
GNCA
11936
PUT
DELISTED
Genocea Biosciences, Inc.
GNCA
$84K ﹤0.01%
67,400
+14,300
+27% +$15.6K
FARM
11937
PUT
DELISTED
Farmer Brothers
FARM
$83K ﹤0.01%
11,600
+900
+8% +$5.85K
LCTX icon
11938
PUT
Lineage Cell Therapeutics
LCTX
$281M
$83K ﹤0.01%
54,100
-24,000
-31% -$37.2K
RLGT icon
11939
Radiant Logistics
RLGT
$408M
$83K ﹤0.01%
+13,062
New +$86.5K
SVM
11940
CALL
Silvercorp Metals
SVM
$2.82B
$83K ﹤0.01%
22,800
+7,200
+46% +$26.3K
TCRT icon
11941
PUT
Alaunos Therapeutics
TCRT
$4.06M
$83K ﹤0.01%
854
-537
-39% -$68.9K
PMD
11942
DELISTED
Psychemedics Corporation
PMD
$83K ﹤0.01%
+11,910
New +$84.3K
BCEL
11943
PUT
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$83K ﹤0.01%
26,100
-6,700
-20% -$16.3K
VRAY
11944
DELISTED
ViewRay, Inc.
VRAY
$83K ﹤0.01%
21,206
+5,840
+38% +$24.9K
CHRA
11945
CALL
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$83K ﹤0.01%
+1,660
New +$85K
BCDA icon
11946
PUT
BioCardia
BCDA
$17.4M
$82K ﹤0.01%
2,647
-833
-24% -$24.7K
FSI icon
11947
Flexible Solutions
FSI
$74.1M
$82K ﹤0.01%
+20,103
New +$73.1K
PTPI
11948
CALL
DELISTED
Petros Pharmaceuticals
PTPI
$82K ﹤0.01%
211
+55
+35% +$23.2K
VANI icon
11949
CALL
Vivani Medical
VANI
$128M
$82K ﹤0.01%
19,033
+10,100
+113% +$42.5K
CSCI
11950
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$82K ﹤0.01%
2,227
-514
-19% -$18.5K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.